Human respiratory syncytial virus (HRSV) is a major cause of upper and lower respiratory
tract illness in infants and young children worldwide. Despite its importance as a respiratory …

Respiratory syncytial virus (RSV) is the main cause of acute respiratory tract infections in
infants and it also induces significant disease in the elderly. The clinical course may be …

Introduction: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract
infection in infants and elderly and to date, there is no safe or effective vaccine against RSV …

Respiratory syncytial virus (RSV) was first isolated from chimpanzees in 1955, and shortly
thereafter from young children, and recognized as an important cause of serious lower …

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract viral disease
in infants and young children. Presently, there are no explicit recommendations for RSV …

Respiratory syncytial virus (RSV) causes a significant proportion of the global burden of
respiratory disease. Here we summarize the conclusions of a series of chapters written by …

The development of an effective vaccine against respiratory syncytial virus (RSV) has been
hampered by major difficulties that occurred in the 1960s when a formalin-inactivated …

Although RSV has been a high priority for vaccine development, efforts to develop a safe
and effective vaccine have yet to lead to a licensed product. Clinical and epidemiologic …

Introduction: Human respiratory syncytial virus (RSV) is a major health threat both for the
very young and the elderly. With yearly 3.2 million hospital admissions and approximately …

Respiratory syncytial virus (RSV) is the leading cause of serious lower respiratory track
illness causing bronchiolitis and some mortality in infants and the elderly. Despite decades …